Julia Ma, PhD

Executive Director, Global Medical Affairs & HTA Statistics
AbbVie
Madison, New Jersey

Disclosure information not submitted.

Presentation(s):

• Improvement in Patient-Reported Outcomes When Ubrogepant Is Administered During the Migraine Prodrome (Premonitory Phase): Results From the PRODROME Trial

  POSTER ABSTRACT